About Synedgen
Synedgen is a private company based in Claremont, California. It has reported $24,336,397 raised in eight offerings on Form D since October 2009. Its chief executive is Shenda Baker.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2024 | Oct 1, 2024 | $1,750,000of $2.0M target | 4 | $437K | DebtRule 506(b) | Form D ↗ |
| Jun 30, 2019 | Jul 12, 2019 | $2,500,000of $3.0M target | 1 | $2.5M | Right to receive share of certain profits, out-licensing proceeds, intellectual property enforcement, and liquidation proceeds, in each case attributable to the issuer's wound care business division.Rule 506(b) | Form D ↗ |
| Aug 30, 2017 | Sep 12, 2017 | $3,000,000fully sold | 3 | $1.0M | DebtRule 506(b) | Form D ↗ |
| Oct 28, 2016 | Nov 8, 2016 | $3,000,000of $3.5M target | 1 | $3.0M | DebtRule 506(b) | Form D ↗ |
| Apr 13, 2016 | Apr 27, 2016 | $6,000,000of $6.5M target | 1 | $6.0M | Contractual RightsRule 506(b) | Form D ↗ |
| Feb 24, 2015 | Mar 3, 2015 | $3,500,000of $4.0M target | 1 | $3.5M | EquityRule 506(b) | Form D ↗ |
| Aug 7, 2014 | Aug 13, 2014 | $607,440fully sold | 15 | $40,496 | EquityRule 506(b) | Form D ↗ |
| Oct 10, 2009 | Oct 20, 2009amended Jul 12, 2013 | $3,978,957of $4.0M target | 38 | $104K | Equity06 | Form D/A ↗7 earlier filings |
| Total, eight offerings | $24,336,397 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Synedgen's Form D filed Oct 1, 2024.

Earlier filings also listed William Wiesmann, M.D. (executive officer and director, last listed Jul 2019), Paul Grint, M.D. (director, last listed Jul 2019), Kenton Gregory, M.D. (director, last listed Jul 2019), Robert Coughlin (director, last listed Sep 2017), William Weismann (executive officer and director, last listed Nov 2016), Larry Shapiro (director, last listed Nov 2016), Diane Olmstead (director, last listed Apr 2016) and Clarke Atwell (director, last listed Apr 2016).
Sources
- SECSynedgen, Inc. Form D/A, filed Apr 29, 2013
- SECSynedgen, Inc. Form D/A, filed May 14, 2012
- SECSynedgen, Inc. Form D/A, filed May 14, 2012
- SECSynedgen, Inc. Form D/A, filed May 14, 2012
- SECSynedgen, Inc. Form D/A, filed May 14, 2012
- SECSynedgen, Inc. Form D/A, filed Sep 14, 2011
- SECSynedgen, Inc. Form D, filed Oct 20, 2009
- SECSynedgen, Inc. filing history